Clusters of risk factors in metabolic syndrome and their influence on central blood pressure in a global study

Agne Laucyte-Cibulskiene*, Chen Huan Chen, John Cockroft, Pedro G. Cunha, Maryam Kavousi, Aleksandras Laucevicius, Maria Lorenza Muiesan, Ernst R. Rietzschel, Ligita Ryliskyte, Irina D. Strazhesko, Charalambos Vlachopoulos, Jorge Cotter, Ekatherina N. Dudinskaya, Nichola Gale, Fariba Ahmadizar, Francesco U.S. Mattace-Raso, Maggie Munnery, Pedro Oliveira, Anna Paini, Massimo SalvettiOlga N. Tkacheva, Edward G. Lakatta, Peter M. Nilsson, Angelo Scuteri


研究成果: Article同行評審

1 引文 斯高帕斯(Scopus)


The effect of metabolic syndrome (MetS) and clusters of its components on central blood pressure (CBP) has not been well characterized. We aimed to describe the effect of MetS and clusters of its components on CBP in a large population and to identify whether this effect differs in men and women. We studied 15,609 volunteers (43% women) from 10 cohorts worldwide who participated in the Metabolic syndrome and Artery REsearch Consortium. MetS was defined according to the NCEP-ATP III criteria (GHTBW, glucose, high-density lipoprotein cholesterol, triglyceride, blood pressure, waist circumference). CBP was measured noninvasively and acquired from pulse wave analysis by applanation tonometry. MetS was associated with a 50% greater odds of having higher CSBP. After controlling for age, male sex, non HDL cholesterol, diabetes mellitus, and mean arterial pressure, only specific clusters of MetS components were associated with a higher CSBP; and some of them were significant in women but not in men. We identified “risky clusters” of MetS variables associated with high CSBP. Future studies are needed to confirm they identify subjects at high risk of accelerated arterial aging and, thus, need more intensive clinical management.

期刊Scientific reports
出版狀態Published - 12月 2022


深入研究「Clusters of risk factors in metabolic syndrome and their influence on central blood pressure in a global study」主題。共同形成了獨特的指紋。